Vectorious Medical Technologies
Latest round
- Series B
Last raised
- Jul 2018
Total raised
- $12M
Investors
- 6
About Vectorious Medical Technologies
Vectorious Medical Technologies Ltd.Founded in 2011 by co-founders Eyal Orion, and Oren Goldstein, Vectorious Medical Technologies Ltd. operates from Tel Aviv-Yafo, Israel. The company focuses on innovative cardiac monitoring solutions, with its flagship product, the V-LAP System, designed to aid in chronic heart failure management. In September 2025, Edwards Lifesciences Corp, fully acquired Vectorious Medical Technologies Ltd. from Broadview Ventures, Champel Capital, EASME, Fresenius Medical Care Ventures, Global Cardiovascular Innovation Center, Go Capital, and RAD BioMed. Following the transaction, Edwards Lifesciences fully owns the company. The company valued at USD 497 million. Vectorious specializes in innovative cardiac monitoring solutions, primarily focusing on their flagship product, the V-LAP System. This investigational device is implanted in the heart's interatrial septum to continuously measure left atrial pressure (LAP), allowing for real-time data transmission that supports physician-guided, patient self-management of chronic heart failure. The system is designed to empower patients by providing daily insights into their heart health, thereby addressing critical challenges associated with heart failure management. The V-LAP System has garnered interest from healthcare providers looking to enhance patient outcomes through advanced monitoring technology.Vectorious's revenue model primarily revolves around the provision of their V-LAP System for clinical investigation. The company engages in partnerships with healthcare providers and research institutions, facilitating clinical trials and data collection while focusing on improving heart failure management. Transactions are structured to support the integration of this investigational device into clinical settings, with the potential for future applications in hospitals and outpatient care environments. In December 2025, Edwards Lifesciences Corp, fully acquired Vectorious Medical Technologies Ltd. from Broadview Ventures, Champel Capital, EASME, Fresenius Medical Care Ventures, Global Cardiovascular Innovation Center, Go Capital, and RAD BioMed. Financial terms of the transaction were not disclosed. The December 2025 acquisition aims to provide Edwards Lifesciences Corp access to Vectorious Medical Technologies Ltd. and capability for Left Atrial Filling Pressure implantable device.
Who invested in Vectorious Medical Technologies
6 investors across 4 rounds
See all investors in Vectorious Medical Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vectorious Medical Technologies
Who invested in Vectorious Medical Technologies?
Vectorious Medical Technologies has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vectorious Medical Technologies raised?
Vectorious Medical Technologies has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Vectorious Medical Technologies last raise money?
Vectorious Medical Technologies's most recent round on record is a Series B, in Jul 2018.
What does Vectorious Medical Technologies do?
Vectorious Medical Technologies Ltd.
Where is Vectorious Medical Technologies headquartered?
Vectorious Medical Technologies is headquartered in Tel Aviv-Yafo, Israel.
Which VCs invest in companies like Vectorious Medical Technologies?
Among active investors with capital left to deploy, Yufu Capital, ICBC Capital Management, Ningbo Tongshang Fund and Boc Private Equity Firm back software companies at Vectorious Medical Technologies's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Vectorious Medical Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.